Nisa Investment Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,686
| Closed | -$634 | – | 2385 |
|
|
2021
Q3 | $634 | Sell |
3,686
-2,582
| -41% | -$444 | ﹤0.01% | 1051 |
|
|
2021
Q2 | $787 | Hold |
6,268
| – | – | ﹤0.01% | 1014 |
|
|
2021
Q1 | $850 | Buy |
6,268
+300
| +5% | +$41 | 0.01% | 1024 |
|
|
2020
Q4 | $764K | Buy |
5,968
+2,242
| +60% | +$287K | ﹤0.01% | 1033 |
|
|
2020
Q3 | $419K | Buy |
3,726
+150
| +4% | +$16.9K | ﹤0.01% | 1097 |
|
|
2020
Q2 | $341K | Buy |
3,576
+2,291
| +178% | +$218K | ﹤0.01% | 1149 |
|
|
2020
Q1 | $115K | Sell |
1,285
-320
| -20% | -$28.6K | ﹤0.01% | 1333 |
|
|
2019
Q4 | $85K | Sell |
1,605
-2,695
| -63% | -$143K | ﹤0.01% | 1462 |
|
|
2019
Q3 | $170K | Buy |
4,300
+4,090
| +1,948% | +$162K | ﹤0.01% | 1361 |
|
|
2019
Q2 | $9K | Hold |
210
| – | – | ﹤0.01% | 1795 |
|
|
2019
Q1 | $10K | Hold |
210
| – | – | ﹤0.01% | 1770 |
|
|
2018
Q4 | $9K | Hold |
210
| – | – | ﹤0.01% | 1687 |
|
|
2018
Q3 | $12K | Hold |
210
| – | – | ﹤0.01% | 1682 |
|
|
2018
Q2 | $10K | Hold |
210
| – | – | ﹤0.01% | 1745 |
|
|
2018
Q1 | $8K | Sell |
210
-150
| -42% | -$5.71K | ﹤0.01% | 1723 |
|
|
2017
Q4 | $15K | Hold |
360
| – | – | ﹤0.01% | 1630 |
|
|
2017
Q3 | $13K | Hold |
360
| – | – | ﹤0.01% | 1677 |
|
|
2017
Q2 | $11K | Buy |
360
+150
| +71% | +$4.58K | ﹤0.01% | 1702 |
|
|
2017
Q1 | $6K | Sell |
210
-190
| -48% | -$5.43K | ﹤0.01% | 1792 |
|
|
2016
Q4 | $10K | Buy |
+400
| New | +$10K | ﹤0.01% | 1807 |
|